R. Carter Pate
R. Carter Pate's purchase track record
How the stock did after each of R. Carter Pate's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/20/2025 | OPCH | $20K | +2.0% | +30.4% | +7.6% |
| 8/17/2023 | OPCH | $50K | -15.3% | -2.4% | +15.1% |
| 5/15/2023 | PRPL | $50K | -22.7% | -80.5% | +6.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
No recent PRPL news found; context limited to technicals. The provided news article concerns Kimberly-Clark and does not relate to Purple Innovation. Therefore, no specific recent corporate developments can be summarized for this symbol. Technical indicators show the stock is in an oversold zone with high volatility, but without relevant news, the primary driver of current sentiment remains unclear.
Transaction History
| OPCH | ▲ Buy | Grant | 8,997 | $0 | 5/20/2026 | View on chart |
| OPCH | ▼ Sell | Open Market | 30,287 | $971K | 2/27/2026 | View on chart |
| OPCH | ▲ Buy | Open Market | 750 | $20K | 8/20/2025 | View on chart |
| OPCH | ▲ Buy | Grant | 5,034 | $0 | 5/14/2025 | View on chart |
| OPCH | ▼ Sell | Gift | 67,342 | $0 | 9/3/2024 | View on chart |
| OPCH | ▼ Sell | Open Market | 1,465 | $47K | 9/3/2024 | View on chart |
| OPCH | ▲ Buy | Grant | 5,325 | $0 | 5/15/2024 | View on chart |
| OPCH | ▼ Sell | Gift | 6,504 | $0 | 5/9/2024 | View on chart |
| OPCH | ▲ Buy | Open Market | 1,465 | $50K | 8/17/2023 | View on chart |
| PRPL | ▲ Buy | Grant | 31,765 | $0 | 6/20/2023 | View on chart |
| OPCH | ▲ Buy | Grant | 9,117 | $0 | 5/17/2023 | View on chart |
| PRPL | ▲ Buy | Open Market | 16,949 | $50K | 5/15/2023 | View on chart |
| OPCH | ▼ Sell | Open Market | 1,928 | $62K | 10/3/2022 | View on chart |
| OPCH | ▼ Sell | Open Market | 1,923 | $59K | 9/1/2022 | View on chart |
| OPCH | ▼ Sell | Open Market | 1,923 | $64K | 8/1/2022 | View on chart |
| OPCH | ▼ Sell | Open Market | 1,923 | $58K | 7/8/2022 | View on chart |
| OPCH | ▼ Sell | Open Market | 1,923 | $59K | 6/1/2022 | View on chart |
| OPCH | ▲ Buy | Grant | 8,898 | $0 | 5/20/2022 | View on chart |
| OPCH | ▼ Sell | Open Market | 5,125 | $138K | 12/21/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
McKesson moves to acquire Option Care Health in $5.8B deal
Option Care Health is the target of a $5.8 billion acquisition by McKesson, which has lifted the stock in recent trading. The deal is under legal review, and several analysts have lowered their ratings, with UBS moving to neutral and William Blair to market‑perform. The mixed reactions reflect both the premium offered and the uncertainties around regulatory approval.
McKesson moves to acquire Option Care Health in $5.8B deal. Option Care Health is the target of a $5.8 billion acquisition by McKesson, which has lifted the stock in recent trading. The deal is under legal review, and several analysts have lowered their ratings, with UBS moving to neutral and William Blair to market‑perform. The mixed reactions reflect both the premium offered and the uncertainties around regulatory approval.